Branchpoint & Aura Development LLC

Branchpoint & Aura Development LLC specializes in intracranial pressure monitoring systems, including short-term intracerebral sensor catheters and ambulatory monitoring appliances. Their product line also includes portable rechargeable battery packs, noninvasive battery chargers, and removable skin-adherent patches for continuous monitoring. Additionally, they produce medical networking interface units and transceiver/cable systems designed for data transmission in ambulatory monitoring setups.

The company is headquartered in the United States, though the exact location is not specified. This base of operations influences its regulatory compliance and reporting requirements under U.S. medical device regulations.

The company’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices for regulatory, safety, and market surveillance purposes, ensuring traceability and compliance with U.S. requirements.

All of Branchpoint & Aura Development LLC’s devices fall under Class II classification by the FDA. This classification typically applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as intracranial pressure monitors and ambulatory monitoring systems.

The FDA’s Unique Device Identifier (UDI) database is mandatory for Class II devices in the U.S. to improve patient safety, enhance device tracking, and support post-market surveillance. Listing ensures transparency in the supply chain, helps with recalls or alerts, and aligns with regulatory requirements for medical device traceability.